Read More Analyst Ratings Downgrades News Needham Downgrades Coupa Software to Hold By Benzinga Newsdesk December 13, 6:37 AM Needham analyst Joshua Reilly downgrades Coupa Software (NASDAQ:COUP) from Buy to Hold. COUP
Read More Markets News Trading Ideas Assessing KKR’s Performance Against Competitors In Capital Markets Industry By Benzinga Insights May 8, 11:00 AM In the ever-changing and fiercely competitive business landscape, conducting thorough company analysis is crucial for investors and industry… KKR
Read More General Media News Tech Tesla’s Chinese Rival BYD Seal A Cost-Effective Contender To Model 3, Says Wall Street Analyst By Benzinga Neuro September 12, 10:46 PM Wall Street analysts have identified a Chinese electric vehicle (EV) that rivals Elon Musk’s Tesla Inc. (NASDAQ:TSLA) Model 3, at… BYDDF
Read More Biotech General News LivaNova Announces 150th Bipolar Depression Patient Randomized In RECOVER Clinical Study By Benzinga Newsdesk June 13, 9:01 AM LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced the 150th bipolar depression patient has been randomized in the RECOVER clinical study, "A Prospective, LIVN